Copyright Reports & Markets. All rights reserved.

Global Procalcitonin (CAS 56645-65-9) Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Procalcitonin (CAS 56645-65-9) Market Overview

      • 1.1 Product Overview and Scope of Procalcitonin (CAS 56645-65-9)
      • 1.2 Procalcitonin (CAS 56645-65-9) Segment by Type
        • 1.2.1 Global Procalcitonin (CAS 56645-65-9) Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Procalcitonin Antigen
        • 1.2.3 Procalcitonin Antibody
      • 1.3 Procalcitonin (CAS 56645-65-9) Segment by Application
        • 1.3.1 Procalcitonin (CAS 56645-65-9) Consumption Comparison by Application (2014-2025)
        • 1.3.2 Medical Industry
        • 1.3.3 Scientific Research
      • 1.3 Global Procalcitonin (CAS 56645-65-9) Market by Region
        • 1.3.1 Global Procalcitonin (CAS 56645-65-9) Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Procalcitonin (CAS 56645-65-9) Market Size
        • 1.4.1 Global Procalcitonin (CAS 56645-65-9) Revenue (2014-2025)
        • 1.4.2 Global Procalcitonin (CAS 56645-65-9) Production (2014-2025)

      2 Global Procalcitonin (CAS 56645-65-9) Market Competition by Manufacturers

      • 2.1 Global Procalcitonin (CAS 56645-65-9) Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Procalcitonin (CAS 56645-65-9) Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Procalcitonin (CAS 56645-65-9) Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Procalcitonin (CAS 56645-65-9) Production Sites, Area Served, Product Types
      • 2.5 Procalcitonin (CAS 56645-65-9) Market Competitive Situation and Trends
        • 2.5.1 Procalcitonin (CAS 56645-65-9) Market Concentration Rate
        • 2.5.2 Procalcitonin (CAS 56645-65-9) Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Procalcitonin (CAS 56645-65-9) Production Market Share by Regions

      • 3.1 Global Procalcitonin (CAS 56645-65-9) Production Market Share by Regions
      • 3.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Procalcitonin (CAS 56645-65-9) Production
        • 3.4.1 North America Procalcitonin (CAS 56645-65-9) Production Growth Rate (2014-2019)
        • 3.4.2 North America Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Procalcitonin (CAS 56645-65-9) Production
        • 3.5.1 Europe Procalcitonin (CAS 56645-65-9) Production Growth Rate (2014-2019)
        • 3.5.2 Europe Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Procalcitonin (CAS 56645-65-9) Production (2014-2019)
        • 3.6.1 China Procalcitonin (CAS 56645-65-9) Production Growth Rate (2014-2019)
        • 3.6.2 China Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Procalcitonin (CAS 56645-65-9) Production (2014-2019)
        • 3.7.1 Japan Procalcitonin (CAS 56645-65-9) Production Growth Rate (2014-2019)
        • 3.7.2 Japan Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Procalcitonin (CAS 56645-65-9) Consumption by Regions

      • 4.1 Global Procalcitonin (CAS 56645-65-9) Consumption by Regions
      • 4.2 North America Procalcitonin (CAS 56645-65-9) Consumption (2014-2019)
      • 4.3 Europe Procalcitonin (CAS 56645-65-9) Consumption (2014-2019)
      • 4.4 China Procalcitonin (CAS 56645-65-9) Consumption (2014-2019)
      • 4.5 Japan Procalcitonin (CAS 56645-65-9) Consumption (2014-2019)

      5 Global Procalcitonin (CAS 56645-65-9) Production, Revenue, Price Trend by Type

      • 5.1 Global Procalcitonin (CAS 56645-65-9) Production Market Share by Type (2014-2019)
      • 5.2 Global Procalcitonin (CAS 56645-65-9) Revenue Market Share by Type (2014-2019)
      • 5.3 Global Procalcitonin (CAS 56645-65-9) Price by Type (2014-2019)
      • 5.4 Global Procalcitonin (CAS 56645-65-9) Production Growth by Type (2014-2019)

      6 Global Procalcitonin (CAS 56645-65-9) Market Analysis by Applications

      • 6.1 Global Procalcitonin (CAS 56645-65-9) Consumption Market Share by Application (2014-2019)
      • 6.2 Global Procalcitonin (CAS 56645-65-9) Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Procalcitonin (CAS 56645-65-9) Business

      • 7.1 Thermo Fisher
        • 7.1.1 Thermo Fisher Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.1.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.1.3 Thermo Fisher Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Roche Diagnostics
        • 7.2.1 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.2.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.2.3 Roche Diagnostics Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 bioMerieux
        • 7.3.1 bioMerieux Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.3.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.3.3 bioMerieux Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 HyTest
        • 7.4.1 HyTest Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.4.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.4.3 HyTest Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 BBI Solutions
        • 7.5.1 BBI Solutions Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.5.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.5.3 BBI Solutions Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 ProSpec
        • 7.6.1 ProSpec Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.6.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.6.3 ProSpec Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Wondfo
        • 7.7.1 Wondfo Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.7.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.7.3 Wondfo Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Ningbo Medicalsystem Biotechnology
        • 7.8.1 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.8.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Wuhan Easy Diagnosis Biomedicine
        • 7.9.1 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.9.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Snibe
        • 7.10.1 Snibe Procalcitonin (CAS 56645-65-9) Production Sites and Area Served
        • 7.10.2 Procalcitonin (CAS 56645-65-9) Product Introduction, Application and Specification
        • 7.10.3 Snibe Procalcitonin (CAS 56645-65-9) Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Vazyme Biotech
      • 7.12 Getein Biotech
      • 7.13 Hotgen Biotech
      • 7.14 Lumigenex
      • 7.15 Nanjing Norman Biological Technology
      • 7.16 Shanghai Medicine'nest Pharmaceutical
      • 7.17 Kitgen
      • 7.18 Beijing KeyGen
      • 7.19 Beijing Apis

      8 Procalcitonin (CAS 56645-65-9) Manufacturing Cost Analysis

      • 8.1 Procalcitonin (CAS 56645-65-9) Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Procalcitonin (CAS 56645-65-9)
      • 8.4 Procalcitonin (CAS 56645-65-9) Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Procalcitonin (CAS 56645-65-9) Distributors List
      • 9.3 Procalcitonin (CAS 56645-65-9) Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Procalcitonin (CAS 56645-65-9) Market Forecast

      • 11.1 Global Procalcitonin (CAS 56645-65-9) Production, Revenue Forecast
        • 11.1.1 Global Procalcitonin (CAS 56645-65-9) Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Procalcitonin (CAS 56645-65-9) Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Procalcitonin (CAS 56645-65-9) Price and Trend Forecast (2019-2025)
      • 11.2 Global Procalcitonin (CAS 56645-65-9) Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Procalcitonin (CAS 56645-65-9) Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Procalcitonin (CAS 56645-65-9) Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Procalcitonin (CAS 56645-65-9) Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Procalcitonin (CAS 56645-65-9) Production, Revenue Forecast (2019-2025)
      • 11.3 Global Procalcitonin (CAS 56645-65-9) Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Procalcitonin (CAS 56645-65-9) Consumption Forecast (2019-2025)
        • 11.3.2 Europe Procalcitonin (CAS 56645-65-9) Consumption Forecast (2019-2025)
        • 11.3.3 China Procalcitonin (CAS 56645-65-9) Consumption Forecast (2019-2025)
        • 11.3.4 Japan Procalcitonin (CAS 56645-65-9) Consumption Forecast (2019-2025)
      • 11.4 Global Procalcitonin (CAS 56645-65-9) Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Procalcitonin (CAS 56645-65-9) Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
        Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
        Expressed in E.coli, PCT can be used as a reagent to prepare calibrators for procalcitonin or calcitonin immunoassays.

        The global procalcitonin market had reached 126.4 g in 2016 and is expected to increase reach 212.6 g by 2023. In terms of revenue, the global procalcitonin chloride market was valued 61.85 Million USD in 2016, and is estimated to be worth 92.27 Million USD by 2023. Overall, the procalcitonin products performance is positive with the global economic recovery.

        The manufacture region is concentrated in USA, Europe, China and Japan, of which Europe is the largest region with the share 36.92% in 2016. The production shares of Europe, China and Japan were 23.07%, 19.12% and 6.43%.

        The consumption share of North America, Europe, Asia Pacific were 26.73%, 28.27%, 35.77% in 2016. Asia Pacific is the main export region.

        There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in Procalcitonin market will become more intense.

        The global Procalcitonin (CAS 56645-65-9) market is valued at 62 million US$ in 2018 is expected to reach 93 million US$ by the end of 2025, growing at a CAGR of 5.2% during 2019-2025.
        This report focuses on Procalcitonin (CAS 56645-65-9) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Procalcitonin (CAS 56645-65-9) market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Thermo Fisher
        Roche Diagnostics
        bioMerieux
        HyTest
        BBI Solutions
        ProSpec
        Wondfo
        Ningbo Medicalsystem Biotechnology
        Wuhan Easy Diagnosis Biomedicine
        Snibe
        Vazyme Biotech
        Getein Biotech
        Hotgen Biotech
        Lumigenex
        Nanjing Norman Biological Technology
        Shanghai Medicine'nest Pharmaceutical
        Kitgen
        Beijing KeyGen
        Beijing Apis

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Procalcitonin Antigen
        Procalcitonin Antibody

        Segment by Application
        Medical Industry
        Scientific Research

        Buy now